These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8102643)

  • 1. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E; Wilson C; Fibiger HC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G; Robertson GS; Tham CS; Fibiger HC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?
    Imperato A; Obinu MC; Gessa GL
    J Neural Transm Suppl; 1995; 45():91-102. PubMed ID: 8748614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y; Thierry AM; Glowinski J; Tassin JP
    Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment.
    Imperato A; Obinu MC; Carta G; Mascia MS; Casu MA; Dazzi L; Gessa GL
    Eur J Pharmacol; 1994 Oct; 264(1):55-60. PubMed ID: 7828643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
    Laplante F; Stevenson CW; Gratton A; Srivastava LK; Quirion R
    J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats.
    Antoniou K; Kehr J; Snitt K; Ogren SO
    Br J Pharmacol; 1997 Jul; 121(6):1180-6. PubMed ID: 9249255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
    Chung YC; Li Z; Dai J; Meltzer HY; Ichikawa J
    Brain Res; 2004 Oct; 1023(1):54-63. PubMed ID: 15364019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Nair SG; Gudelsky GA
    Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S; Wu CF; Fusi R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.